Back
to home » Treatment News » Top Stories
 May 19, 2006
|
Survey: HIV Docs and Patients Don't Always See Eye-to-Eye
According to results of national surveys released today in the Journal of the International Association of Physicians in AIDS Care (JIAPAC), 95% of HIV-treating physicians surveyed said they believe half or fewer of their patients "typically understand" what they are told about HIV and its treatment.
|
|
|
HPV Vaccine Receives Approval Recommendation
An advisory committee to the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend approval of Gardasil®, a vaccine that has been proven to be safe and effective for the prevention of cervical cancer and pre-cancerous lesions of the cervix, vulva, and vagina caused by two common strains of the human papilloma virus (HPV).
|
|
|
May 16, 2006
|
Lexiva vs. Kaletra
GlaxoSmithKline and Vertex Pharmaceuticals have issued a press release reporting the results of a study comparing Lexiva® (also known as Telzir®) combined with Norvir®, to Kaletra®, both in combination with Epzicom.
|
|
|
| May 10, 2006
|
May 05, 2006
|
Updated Treatment Guidelines Published
The Guidelines for the Use of Antiretroviral Agents in HIV Infected Adults and Adolescents have been revised to include up-to-date treatment information, including new recommendations for resistance testing, treatment interruption, and HBV/HIV co-infection.
|
|
|
| May 03, 2006
|
|
|
